New China Life Insurance (01336) has elected Mao Sixue as the director of the Investment Committee of the Eighth Board of Directors.
China Life Insurance (01336) announced that, on February 28, 2025, the 30th meeting of the eighth Board of Directors decided...
New China Life Insurance (01336) announced that at the 30th meeting of the 8th Board of Directors on February 28, 2025, it was resolved to elect Mao Sixue as the Director of the Investment Committee of the 8th Board of Directors, and as a member of the Audit and Related Party Transactions Control Committee. It was also resolved to elect Zhuo Zhi as a member of the Audit and Related Party Transactions Control Committee, and as a member of the Nomination and Remuneration Committee of the 8th Board of Directors. In addition, Yang Xue was appointed as a member of the Strategic Committee of the 8th Board of Directors.
Related Articles

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


